nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Haemoglobin decreased—Sorafenib—liver cancer	0.0214	0.0216	CcSEcCtD
Hyoscyamine—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.0163	0.0165	CcSEcCtD
Hyoscyamine—Blood pressure increased—Sorafenib—liver cancer	0.0147	0.0149	CcSEcCtD
Hyoscyamine—Supraventricular extrasystoles—Epirubicin—liver cancer	0.0146	0.0148	CcSEcCtD
Hyoscyamine—Rash papular—Epirubicin—liver cancer	0.0146	0.0148	CcSEcCtD
Hyoscyamine—Skin exfoliation—Sorafenib—liver cancer	0.0141	0.0142	CcSEcCtD
Hyoscyamine—Supraventricular extrasystoles—Doxorubicin—liver cancer	0.0135	0.0137	CcSEcCtD
Hyoscyamine—Rash papular—Doxorubicin—liver cancer	0.0135	0.0137	CcSEcCtD
Hyoscyamine—Sinus tachycardia—Epirubicin—liver cancer	0.0135	0.0137	CcSEcCtD
Hyoscyamine—Retrosternal pain—Epirubicin—liver cancer	0.0135	0.0137	CcSEcCtD
Hyoscyamine—Retrosternal pain—Doxorubicin—liver cancer	0.0125	0.0126	CcSEcCtD
Hyoscyamine—Sinus tachycardia—Doxorubicin—liver cancer	0.0125	0.0126	CcSEcCtD
Hyoscyamine—Eczema—Sorafenib—liver cancer	0.0119	0.012	CcSEcCtD
Hyoscyamine—Hyponatraemia—Sorafenib—liver cancer	0.0107	0.0108	CcSEcCtD
Hyoscyamine—Dehydration—Sorafenib—liver cancer	0.00995	0.01	CcSEcCtD
Hyoscyamine—Granisetron—CYP1A1—liver cancer	0.00986	1	CrCbGaD
Hyoscyamine—Blindness—Epirubicin—liver cancer	0.00984	0.00993	CcSEcCtD
Hyoscyamine—Dry skin—Sorafenib—liver cancer	0.0098	0.0099	CcSEcCtD
Hyoscyamine—Hypokalaemia—Sorafenib—liver cancer	0.00973	0.00983	CcSEcCtD
Hyoscyamine—Dysphagia—Sorafenib—liver cancer	0.00924	0.00934	CcSEcCtD
Hyoscyamine—Blindness—Doxorubicin—liver cancer	0.0091	0.00919	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Sorafenib—liver cancer	0.00851	0.0086	CcSEcCtD
Hyoscyamine—Keratitis—Epirubicin—liver cancer	0.0084	0.00848	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Sorafenib—liver cancer	0.00813	0.00821	CcSEcCtD
Hyoscyamine—Myocardial infarction—Sorafenib—liver cancer	0.00808	0.00816	CcSEcCtD
Hyoscyamine—Paralysis—Epirubicin—liver cancer	0.00784	0.00792	CcSEcCtD
Hyoscyamine—Keratitis—Doxorubicin—liver cancer	0.00777	0.00785	CcSEcCtD
Hyoscyamine—Laryngitis—Epirubicin—liver cancer	0.00755	0.00763	CcSEcCtD
Hyoscyamine—Ventricular arrhythmia—Epirubicin—liver cancer	0.00736	0.00743	CcSEcCtD
Hyoscyamine—Paralysis—Doxorubicin—liver cancer	0.00725	0.00732	CcSEcCtD
Hyoscyamine—Rash erythematous—Epirubicin—liver cancer	0.00711	0.00718	CcSEcCtD
Hyoscyamine—Laryngitis—Doxorubicin—liver cancer	0.00699	0.00706	CcSEcCtD
Hyoscyamine—Feeling hot—Epirubicin—liver cancer	0.00694	0.00701	CcSEcCtD
Hyoscyamine—Flushing—Sorafenib—liver cancer	0.00687	0.00694	CcSEcCtD
Hyoscyamine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00681	0.00688	CcSEcCtD
Hyoscyamine—Stinging—Epirubicin—liver cancer	0.00672	0.00679	CcSEcCtD
Hyoscyamine—Ageusia—Epirubicin—liver cancer	0.00672	0.00679	CcSEcCtD
Hyoscyamine—Petechiae—Epirubicin—liver cancer	0.00662	0.00668	CcSEcCtD
Hyoscyamine—Arrhythmia—Sorafenib—liver cancer	0.00661	0.00668	CcSEcCtD
Hyoscyamine—Rash erythematous—Doxorubicin—liver cancer	0.00658	0.00664	CcSEcCtD
Hyoscyamine—Blood disorder—Epirubicin—liver cancer	0.00652	0.00658	CcSEcCtD
Hyoscyamine—Mental disorder—Sorafenib—liver cancer	0.00648	0.00655	CcSEcCtD
Hyoscyamine—Erythema—Sorafenib—liver cancer	0.00644	0.00651	CcSEcCtD
Hyoscyamine—Feeling hot—Doxorubicin—liver cancer	0.00642	0.00648	CcSEcCtD
Hyoscyamine—Delirium—Epirubicin—liver cancer	0.00633	0.00639	CcSEcCtD
Hyoscyamine—Dysgeusia—Sorafenib—liver cancer	0.00631	0.00637	CcSEcCtD
Hyoscyamine—Ageusia—Doxorubicin—liver cancer	0.00622	0.00628	CcSEcCtD
Hyoscyamine—Stinging—Doxorubicin—liver cancer	0.00622	0.00628	CcSEcCtD
Hyoscyamine—Petechiae—Doxorubicin—liver cancer	0.00612	0.00619	CcSEcCtD
Hyoscyamine—Blood disorder—Doxorubicin—liver cancer	0.00603	0.00609	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Epirubicin—liver cancer	0.00603	0.00609	CcSEcCtD
Hyoscyamine—Angioedema—Sorafenib—liver cancer	0.00589	0.00594	CcSEcCtD
Hyoscyamine—Delirium—Doxorubicin—liver cancer	0.00586	0.00592	CcSEcCtD
Hyoscyamine—Syncope—Sorafenib—liver cancer	0.00578	0.00583	CcSEcCtD
Hyoscyamine—Dysarthria—Epirubicin—liver cancer	0.00576	0.00581	CcSEcCtD
Hyoscyamine—Loss of consciousness—Sorafenib—liver cancer	0.00566	0.00572	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00558	0.00563	CcSEcCtD
Hyoscyamine—Ventricular tachycardia—Epirubicin—liver cancer	0.00545	0.0055	CcSEcCtD
Hyoscyamine—Injection site reaction—Epirubicin—liver cancer	0.00541	0.00547	CcSEcCtD
Hyoscyamine—Dermatitis contact—Epirubicin—liver cancer	0.00538	0.00544	CcSEcCtD
Hyoscyamine—Dry mouth—Sorafenib—liver cancer	0.00536	0.00542	CcSEcCtD
Hyoscyamine—Dysarthria—Doxorubicin—liver cancer	0.00533	0.00538	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Sorafenib—liver cancer	0.00526	0.00531	CcSEcCtD
Hyoscyamine—Skin exfoliation—Epirubicin—liver cancer	0.0052	0.00525	CcSEcCtD
Hyoscyamine—Shock—Sorafenib—liver cancer	0.00517	0.00522	CcSEcCtD
Hyoscyamine—Blood urea increased—Epirubicin—liver cancer	0.00514	0.00519	CcSEcCtD
Hyoscyamine—Ventricular tachycardia—Doxorubicin—liver cancer	0.00504	0.00509	CcSEcCtD
Hyoscyamine—Dry eye—Epirubicin—liver cancer	0.00503	0.00508	CcSEcCtD
Hyoscyamine—Injection site reaction—Doxorubicin—liver cancer	0.00501	0.00506	CcSEcCtD
Hyoscyamine—Dermatitis contact—Doxorubicin—liver cancer	0.00498	0.00503	CcSEcCtD
Hyoscyamine—Coma—Epirubicin—liver cancer	0.00498	0.00503	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Epirubicin—liver cancer	0.00495	0.005	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Epirubicin—liver cancer	0.00485	0.0049	CcSEcCtD
Hyoscyamine—Skin exfoliation—Doxorubicin—liver cancer	0.00481	0.00486	CcSEcCtD
Hyoscyamine—Hypertonia—Epirubicin—liver cancer	0.00477	0.00482	CcSEcCtD
Hyoscyamine—Blood urea increased—Doxorubicin—liver cancer	0.00476	0.0048	CcSEcCtD
Hyoscyamine—Dyspnoea—Sorafenib—liver cancer	0.00469	0.00473	CcSEcCtD
Hyoscyamine—Dry eye—Doxorubicin—liver cancer	0.00465	0.0047	CcSEcCtD
Hyoscyamine—Dyspepsia—Sorafenib—liver cancer	0.00463	0.00467	CcSEcCtD
Hyoscyamine—Coma—Doxorubicin—liver cancer	0.0046	0.00465	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Doxorubicin—liver cancer	0.00458	0.00463	CcSEcCtD
Hyoscyamine—Fatigue—Sorafenib—liver cancer	0.00453	0.00458	CcSEcCtD
Hyoscyamine—Pain—Sorafenib—liver cancer	0.0045	0.00454	CcSEcCtD
Hyoscyamine—Constipation—Sorafenib—liver cancer	0.0045	0.00454	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Doxorubicin—liver cancer	0.00448	0.00453	CcSEcCtD
Hyoscyamine—Hypertonia—Doxorubicin—liver cancer	0.00442	0.00446	CcSEcCtD
Hyoscyamine—Eczema—Epirubicin—liver cancer	0.0044	0.00444	CcSEcCtD
Hyoscyamine—Eye pain—Epirubicin—liver cancer	0.00438	0.00442	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Sorafenib—liver cancer	0.0043	0.00434	CcSEcCtD
Hyoscyamine—Urticaria—Sorafenib—liver cancer	0.00418	0.00422	CcSEcCtD
Hyoscyamine—Body temperature increased—Sorafenib—liver cancer	0.00416	0.0042	CcSEcCtD
Hyoscyamine—Abdominal pain—Sorafenib—liver cancer	0.00416	0.0042	CcSEcCtD
Hyoscyamine—Eczema—Doxorubicin—liver cancer	0.00407	0.00411	CcSEcCtD
Hyoscyamine—Eye pain—Doxorubicin—liver cancer	0.00405	0.00409	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Epirubicin—liver cancer	0.00405	0.00409	CcSEcCtD
Hyoscyamine—Lethargy—Epirubicin—liver cancer	0.00403	0.00407	CcSEcCtD
Hyoscyamine—Hyponatraemia—Epirubicin—liver cancer	0.00397	0.00401	CcSEcCtD
Hyoscyamine—Osteoarthritis—Epirubicin—liver cancer	0.00395	0.00399	CcSEcCtD
Hyoscyamine—Hypersensitivity—Sorafenib—liver cancer	0.00387	0.00391	CcSEcCtD
Hyoscyamine—Asthenia—Sorafenib—liver cancer	0.00377	0.00381	CcSEcCtD
Hyoscyamine—Cardiac arrest—Epirubicin—liver cancer	0.00376	0.0038	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Doxorubicin—liver cancer	0.00375	0.00379	CcSEcCtD
Hyoscyamine—Lethargy—Doxorubicin—liver cancer	0.00373	0.00377	CcSEcCtD
Hyoscyamine—Pruritus—Sorafenib—liver cancer	0.00372	0.00376	CcSEcCtD
Hyoscyamine—Ataxia—Epirubicin—liver cancer	0.00372	0.00375	CcSEcCtD
Hyoscyamine—Dehydration—Epirubicin—liver cancer	0.00368	0.00371	CcSEcCtD
Hyoscyamine—Hyponatraemia—Doxorubicin—liver cancer	0.00367	0.00371	CcSEcCtD
Hyoscyamine—Osteoarthritis—Doxorubicin—liver cancer	0.00366	0.00369	CcSEcCtD
Hyoscyamine—Dry skin—Epirubicin—liver cancer	0.00362	0.00366	CcSEcCtD
Hyoscyamine—Hypokalaemia—Epirubicin—liver cancer	0.0036	0.00363	CcSEcCtD
Hyoscyamine—Diarrhoea—Sorafenib—liver cancer	0.0036	0.00363	CcSEcCtD
Hyoscyamine—Cardiac arrest—Doxorubicin—liver cancer	0.00348	0.00351	CcSEcCtD
Hyoscyamine—Dizziness—Sorafenib—liver cancer	0.00348	0.00351	CcSEcCtD
Hyoscyamine—Abdominal distension—Epirubicin—liver cancer	0.00344	0.00347	CcSEcCtD
Hyoscyamine—Ataxia—Doxorubicin—liver cancer	0.00344	0.00347	CcSEcCtD
Hyoscyamine—Dysphagia—Epirubicin—liver cancer	0.00342	0.00345	CcSEcCtD
Hyoscyamine—Dehydration—Doxorubicin—liver cancer	0.0034	0.00344	CcSEcCtD
Hyoscyamine—Dry skin—Doxorubicin—liver cancer	0.00335	0.00339	CcSEcCtD
Hyoscyamine—Vomiting—Sorafenib—liver cancer	0.00334	0.00338	CcSEcCtD
Hyoscyamine—Hypokalaemia—Doxorubicin—liver cancer	0.00333	0.00336	CcSEcCtD
Hyoscyamine—Angina pectoris—Epirubicin—liver cancer	0.00333	0.00336	CcSEcCtD
Hyoscyamine—Rash—Sorafenib—liver cancer	0.00331	0.00335	CcSEcCtD
Hyoscyamine—Dermatitis—Sorafenib—liver cancer	0.00331	0.00334	CcSEcCtD
Hyoscyamine—Headache—Sorafenib—liver cancer	0.00329	0.00333	CcSEcCtD
Hyoscyamine—Dysuria—Epirubicin—liver cancer	0.00319	0.00323	CcSEcCtD
Hyoscyamine—Abdominal distension—Doxorubicin—liver cancer	0.00318	0.00321	CcSEcCtD
Hyoscyamine—Dysphagia—Doxorubicin—liver cancer	0.00316	0.00319	CcSEcCtD
Hyoscyamine—Nausea—Sorafenib—liver cancer	0.00312	0.00315	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Epirubicin—liver cancer	0.00308	0.00311	CcSEcCtD
Hyoscyamine—Angina pectoris—Doxorubicin—liver cancer	0.00308	0.00311	CcSEcCtD
Hyoscyamine—Drowsiness—Epirubicin—liver cancer	0.00305	0.00308	CcSEcCtD
Hyoscyamine—Conjunctivitis—Epirubicin—liver cancer	0.00296	0.00299	CcSEcCtD
Hyoscyamine—Dysuria—Doxorubicin—liver cancer	0.00296	0.00299	CcSEcCtD
Hyoscyamine—Sweating—Epirubicin—liver cancer	0.00292	0.00295	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Doxorubicin—liver cancer	0.00285	0.00288	CcSEcCtD
Hyoscyamine—Drowsiness—Doxorubicin—liver cancer	0.00282	0.00285	CcSEcCtD
Hyoscyamine—Bradycardia—Epirubicin—liver cancer	0.00278	0.00281	CcSEcCtD
Hyoscyamine—Conjunctivitis—Doxorubicin—liver cancer	0.00274	0.00277	CcSEcCtD
Hyoscyamine—Sweating—Doxorubicin—liver cancer	0.0027	0.00273	CcSEcCtD
Hyoscyamine—Bradycardia—Doxorubicin—liver cancer	0.00258	0.0026	CcSEcCtD
Hyoscyamine—Flushing—Epirubicin—liver cancer	0.00254	0.00256	CcSEcCtD
Hyoscyamine—Arrhythmia—Epirubicin—liver cancer	0.00244	0.00247	CcSEcCtD
Hyoscyamine—Mental disorder—Epirubicin—liver cancer	0.0024	0.00242	CcSEcCtD
Hyoscyamine—Erythema—Epirubicin—liver cancer	0.00238	0.0024	CcSEcCtD
Hyoscyamine—Flushing—Doxorubicin—liver cancer	0.00235	0.00237	CcSEcCtD
Hyoscyamine—Tension—Epirubicin—liver cancer	0.00234	0.00236	CcSEcCtD
Hyoscyamine—Dysgeusia—Epirubicin—liver cancer	0.00233	0.00235	CcSEcCtD
Hyoscyamine—Nervousness—Epirubicin—liver cancer	0.00231	0.00234	CcSEcCtD
Hyoscyamine—Arrhythmia—Doxorubicin—liver cancer	0.00226	0.00228	CcSEcCtD
Hyoscyamine—Vision blurred—Epirubicin—liver cancer	0.00224	0.00227	CcSEcCtD
Hyoscyamine—Mental disorder—Doxorubicin—liver cancer	0.00222	0.00224	CcSEcCtD
Hyoscyamine—Erythema—Doxorubicin—liver cancer	0.0022	0.00222	CcSEcCtD
Hyoscyamine—Agitation—Epirubicin—liver cancer	0.00219	0.00221	CcSEcCtD
Hyoscyamine—Tension—Doxorubicin—liver cancer	0.00216	0.00218	CcSEcCtD
Hyoscyamine—Dysgeusia—Doxorubicin—liver cancer	0.00216	0.00218	CcSEcCtD
Hyoscyamine—Nervousness—Doxorubicin—liver cancer	0.00214	0.00216	CcSEcCtD
Hyoscyamine—Vertigo—Epirubicin—liver cancer	0.00214	0.00216	CcSEcCtD
Hyoscyamine—Syncope—Epirubicin—liver cancer	0.00213	0.00216	CcSEcCtD
Hyoscyamine—Palpitations—Epirubicin—liver cancer	0.0021	0.00212	CcSEcCtD
Hyoscyamine—Loss of consciousness—Epirubicin—liver cancer	0.00209	0.00211	CcSEcCtD
Hyoscyamine—Vision blurred—Doxorubicin—liver cancer	0.00208	0.0021	CcSEcCtD
Hyoscyamine—Convulsion—Epirubicin—liver cancer	0.00206	0.00208	CcSEcCtD
Hyoscyamine—Chest pain—Epirubicin—liver cancer	0.00203	0.00205	CcSEcCtD
Hyoscyamine—Agitation—Doxorubicin—liver cancer	0.00202	0.00204	CcSEcCtD
Hyoscyamine—Anxiety—Epirubicin—liver cancer	0.00202	0.00204	CcSEcCtD
Hyoscyamine—Dry mouth—Epirubicin—liver cancer	0.00198	0.002	CcSEcCtD
Hyoscyamine—Vertigo—Doxorubicin—liver cancer	0.00198	0.002	CcSEcCtD
Hyoscyamine—Syncope—Doxorubicin—liver cancer	0.00198	0.00199	CcSEcCtD
Hyoscyamine—Confusional state—Epirubicin—liver cancer	0.00196	0.00198	CcSEcCtD
Hyoscyamine—Palpitations—Doxorubicin—liver cancer	0.00195	0.00197	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Epirubicin—liver cancer	0.00194	0.00196	CcSEcCtD
Hyoscyamine—Oedema—Epirubicin—liver cancer	0.00194	0.00196	CcSEcCtD
Hyoscyamine—Loss of consciousness—Doxorubicin—liver cancer	0.00194	0.00196	CcSEcCtD
Hyoscyamine—Shock—Epirubicin—liver cancer	0.00191	0.00193	CcSEcCtD
Hyoscyamine—Convulsion—Doxorubicin—liver cancer	0.00191	0.00193	CcSEcCtD
Hyoscyamine—Tachycardia—Epirubicin—liver cancer	0.0019	0.00192	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Epirubicin—liver cancer	0.00188	0.0019	CcSEcCtD
Hyoscyamine—Chest pain—Doxorubicin—liver cancer	0.00188	0.00189	CcSEcCtD
Hyoscyamine—Anxiety—Doxorubicin—liver cancer	0.00187	0.00189	CcSEcCtD
Hyoscyamine—Dry mouth—Doxorubicin—liver cancer	0.00183	0.00185	CcSEcCtD
Hyoscyamine—Hypotension—Epirubicin—liver cancer	0.00182	0.00183	CcSEcCtD
Hyoscyamine—Confusional state—Doxorubicin—liver cancer	0.00181	0.00183	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Doxorubicin—liver cancer	0.0018	0.00182	CcSEcCtD
Hyoscyamine—Oedema—Doxorubicin—liver cancer	0.0018	0.00182	CcSEcCtD
Hyoscyamine—Shock—Doxorubicin—liver cancer	0.00177	0.00179	CcSEcCtD
Hyoscyamine—Insomnia—Epirubicin—liver cancer	0.00176	0.00177	CcSEcCtD
Hyoscyamine—Tachycardia—Doxorubicin—liver cancer	0.00175	0.00177	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Doxorubicin—liver cancer	0.00174	0.00176	CcSEcCtD
Hyoscyamine—Dyspnoea—Epirubicin—liver cancer	0.00173	0.00175	CcSEcCtD
Hyoscyamine—Somnolence—Epirubicin—liver cancer	0.00173	0.00174	CcSEcCtD
Hyoscyamine—Dyspepsia—Epirubicin—liver cancer	0.00171	0.00173	CcSEcCtD
Hyoscyamine—Hypotension—Doxorubicin—liver cancer	0.00168	0.0017	CcSEcCtD
Hyoscyamine—Fatigue—Epirubicin—liver cancer	0.00167	0.00169	CcSEcCtD
Hyoscyamine—Pain—Epirubicin—liver cancer	0.00166	0.00168	CcSEcCtD
Hyoscyamine—Constipation—Epirubicin—liver cancer	0.00166	0.00168	CcSEcCtD
Hyoscyamine—Insomnia—Doxorubicin—liver cancer	0.00163	0.00164	CcSEcCtD
Hyoscyamine—Dyspnoea—Doxorubicin—liver cancer	0.0016	0.00162	CcSEcCtD
Hyoscyamine—Feeling abnormal—Epirubicin—liver cancer	0.0016	0.00162	CcSEcCtD
Hyoscyamine—Somnolence—Doxorubicin—liver cancer	0.0016	0.00161	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Epirubicin—liver cancer	0.00159	0.0016	CcSEcCtD
Hyoscyamine—Dyspepsia—Doxorubicin—liver cancer	0.00158	0.0016	CcSEcCtD
Hyoscyamine—Fatigue—Doxorubicin—liver cancer	0.00155	0.00157	CcSEcCtD
Hyoscyamine—Urticaria—Epirubicin—liver cancer	0.00154	0.00156	CcSEcCtD
Hyoscyamine—Pain—Doxorubicin—liver cancer	0.00154	0.00155	CcSEcCtD
Hyoscyamine—Constipation—Doxorubicin—liver cancer	0.00154	0.00155	CcSEcCtD
Hyoscyamine—Abdominal pain—Epirubicin—liver cancer	0.00154	0.00155	CcSEcCtD
Hyoscyamine—Body temperature increased—Epirubicin—liver cancer	0.00154	0.00155	CcSEcCtD
Hyoscyamine—Feeling abnormal—Doxorubicin—liver cancer	0.00148	0.0015	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00147	0.00148	CcSEcCtD
Hyoscyamine—Hypersensitivity—Epirubicin—liver cancer	0.00143	0.00145	CcSEcCtD
Hyoscyamine—Urticaria—Doxorubicin—liver cancer	0.00143	0.00144	CcSEcCtD
Hyoscyamine—Body temperature increased—Doxorubicin—liver cancer	0.00142	0.00144	CcSEcCtD
Hyoscyamine—Abdominal pain—Doxorubicin—liver cancer	0.00142	0.00144	CcSEcCtD
Hyoscyamine—Asthenia—Epirubicin—liver cancer	0.00139	0.00141	CcSEcCtD
Hyoscyamine—Pruritus—Epirubicin—liver cancer	0.00137	0.00139	CcSEcCtD
Hyoscyamine—Diarrhoea—Epirubicin—liver cancer	0.00133	0.00134	CcSEcCtD
Hyoscyamine—Hypersensitivity—Doxorubicin—liver cancer	0.00132	0.00134	CcSEcCtD
Hyoscyamine—Asthenia—Doxorubicin—liver cancer	0.00129	0.0013	CcSEcCtD
Hyoscyamine—Dizziness—Epirubicin—liver cancer	0.00128	0.0013	CcSEcCtD
Hyoscyamine—Pruritus—Doxorubicin—liver cancer	0.00127	0.00128	CcSEcCtD
Hyoscyamine—Vomiting—Epirubicin—liver cancer	0.00124	0.00125	CcSEcCtD
Hyoscyamine—Diarrhoea—Doxorubicin—liver cancer	0.00123	0.00124	CcSEcCtD
Hyoscyamine—Rash—Epirubicin—liver cancer	0.00122	0.00124	CcSEcCtD
Hyoscyamine—Dermatitis—Epirubicin—liver cancer	0.00122	0.00124	CcSEcCtD
Hyoscyamine—Headache—Epirubicin—liver cancer	0.00122	0.00123	CcSEcCtD
Hyoscyamine—Dizziness—Doxorubicin—liver cancer	0.00119	0.0012	CcSEcCtD
Hyoscyamine—Nausea—Epirubicin—liver cancer	0.00115	0.00117	CcSEcCtD
Hyoscyamine—Vomiting—Doxorubicin—liver cancer	0.00114	0.00115	CcSEcCtD
Hyoscyamine—Rash—Doxorubicin—liver cancer	0.00113	0.00114	CcSEcCtD
Hyoscyamine—Dermatitis—Doxorubicin—liver cancer	0.00113	0.00114	CcSEcCtD
Hyoscyamine—Headache—Doxorubicin—liver cancer	0.00113	0.00114	CcSEcCtD
Hyoscyamine—Nausea—Doxorubicin—liver cancer	0.00107	0.00108	CcSEcCtD
